Document is current
Any future updates will be listed below
-
Authors
Bass, E. J. https://orcid.org/0000-0002-4923-572X
Pantovic, A.
Connor, M. https://orcid.org/0000-0003-4033-7508
Gabe, R.
Padhani, A. R. https://orcid.org/0000-0002-5830-5777
Rockall, A.
Sokhi, H.
Tam, H.
Winkler, M.
Ahmed, H. U. https://orcid.org/0000-0003-1674-6723
- License Information
-
More Information
Article History
Received: 6 August 2020
Revised: 14 October 2020
Accepted: 19 October 2020
First Online: 20 November 2020
Compliance with ethical standards
:
: HUA’s research is supported by core funding from the United Kingdom’s National Institute of Health Research (NIHR) Imperial Biomedical Research Centre. HUA currently receives funding from the Wellcome Trust, Medical Research Council (UK), Cancer Research UK, Prostate Cancer UK, The Urology Foundation, BMA Foundation, Imperial Health Charity, NIHR Imperial BRC, Sonacare Inc., Trod Medical and Sophiris Biocorp for trials in prostate cancer. HUA was a paid medical consultant for Sophiris Biocorp in the previous 3 years.
